title: Drug interactions between cyclosporine and rifampicin, erythromycin, and azoles in kidney recipients with opportunistic infections.
authors.affiliation: Department of Nephrology, University Medical Centre, Ljubljana, Slovenia.
authors.forename: M
authors.initials: M
authors.lastname: Koselj
authors.forename: A
authors.initials: A
authors.lastname: Bren
authors.forename: A
authors.initials: A
authors.lastname: Kandus
authors.forename: D
authors.initials: D
authors.lastname: Kovac
mesh_terms: D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy; D001393:Azoles / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use*; D004347:Drug Interactions; D004917:Erythromycin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D007877:Legionnaires' Disease / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000188:drug therapy*; D011183:Postoperative Complications; D012293:Rifampin / Q000627:therapeutic use*; D013290:Streptococcal Infections / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
chemical_list: D000935:Antifungal Agents; D001393:Azoles; D004917:Erythromycin; D016572:Cyclosporine; D012293:Rifampin